441. Direct Comparison of EF1α and PGK Promoters Reveals Superior Performance of the PGK Promoter for Expression of the Common Gamma Chain in a Canine.

Slides:

Advertisements

Similar presentations

Revisiting Global Gene Expression Analysis Jakob Lovén, David A. Orlando, Alla A. Sigova, Charles Y. Lin, Peter B. Rahl, Christopher B. Burge, David L.

Advertisements

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.

Jennifer G. Cheung, Krystyna Konopka, Nejat Düzgünes

Volume 20, Issue 2, (February 2012)

414. A Novel Clinical Severity Scoring Measure in Canine X-Linked Myotubular Myopathy: Results Following Systemic AAV Gene Replacement Molecular Therapy

209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.

Statistical Considerations for Immunohistochemistry Panel Development after Gene Expression Profiling of Human Cancers Rebecca A. Betensky, Catherine.

446. Gender Differences in the Osteogenic & Chondrogenic Potential of Human Muscle- Derived Stem Cells In Vitro Alex C. Scibetta, Andrea B. Liebowitz,

Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers Melinda Mata, Stephen.

Genome-editing Technologies for Gene and Cell Therapy

627. Non-Invasive, Multimodal Imaging of Microvesicles with Metabolically Biotinylated, Membrane-Bound Gaussia Luciferase Molecular Therapy Volume.

Elizabeth Morris, Alex Scibetta, Aiping Lu, Xueqin Gao, Johnny Huard

162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo

281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy Molecular Therapy Volume.

Direct Conversion of Skin Cells into Blood: Alchemy or Science?

Molecular Therapy Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)

Evolving Gene Therapy in Primary Immunodeficiency

Volume 20, Issue 6, Pages (June 2012)

343. Benchtop DNA Synthesizer: Oligo-Templated Polymerization (OTP)

Volume 21, Issue 6, Pages (June 2013)

637. Effect of PEG Grafting Degree on Morphology and Transfection Efficiency of Polycation-g-PEG/DNA Nanoparticles Molecular Therapy Volume 20, (May.

John R. Martin, Christopher E. Nelson, Mukesh K

Volume 26, Issue 2, Pages (February 2018)

A Theranostic “SMART” Aptamer for Targeted Therapy of Prostate Cancer

Chen Ling, Baozheng Li, Wenqin Ma, George Aslanidi, Arun Srivastava

The Molecular Pathology of Primary Immunodeficiencies

The Other Face of Chimeric Antigen Receptors

Volume 19, Issue 7, Pages (July 2011)

1060. The MSCV_U3 Internal Promoter Strongly Activates Surrounding Cellular Promoter in Combination with Self_Inactivating (SIN)_MSCV Vector Backbone

724. Blood-Derived Endothelial Progenitor Cells Can Be Isolated With a Novel Method of Diluted Whole Blood Incubation with AMD3100-Induced Mobilization.

Genome-editing Technologies for Gene and Cell Therapy

Premal Lulla, Carlos A. Ramos Molecular Therapy

Molecular Therapy Volume 20, (May 2012) DOI: /S (16)

Molecular Therapy Volume 7, Issue 5, (May 2003) DOI: /S (16)

547. AAV Preparations Contain Contamination from DNA Sequences in Production Plasmids Directly Outside of the ITRs Mark A. Brimble, Junfang Zhou, Christopher.

847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach Molecular.

611. Alpha-Dystrobrevin-3 Prevents Myopathy and Restores Diaphragm Function in the Alpha-Dystrobrevin Null Mouse Guy L. Odom, Glen B. Banks, Marvin E.

Designer Lipids Advance Systemic siRNA Delivery

Volume 20, Issue 6, Pages (June 2012)

133. Survival with Normal Neurological Development of the Juvenile Lethal Urea Cycle Defect Arginase Deficient Mouse with AAV Gene Therapy Molecular.

660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy Geeta Shroff Molecular Therapy

Volume 26, Issue 2, Pages (February 2018)

68. Site Specific Intra-Placental Gene Transfer Corrects Fetal Growth Restriction in a Novel Mouse Model of Placental Insufficiency (PI) Molecular.

521. Multiplex Genome Editing of TCR°/CD52 Genes as a Platform for “Off the Shelf” Adoptive T-Cell Immunotherapies Molecular Therapy Volume 22, Pages.

Jennifer G. Cheung, Krystyna Konopka, Nejat Düzgünes

Chae-lyul Limg, Yeon-Ju Lee, Sujeong Kim

335. High Content Analysis Platform for Optimization of Lipid Mediated CRISPR-Cas9 Delivery Strategies in Human Cells Benjamin Steyer, Jared Carlson-Stevermer,

186. Long-Term Results of pCMV-vegf165 Intramuscular Gene Transfer in Patients With Chronic Lower Limb Ischemia Ilia Y. Bozo, Roman V. Deev, Igor L.

405. Hindlimb and Forelimb Strength Assessment in a Canine Model of X-Linked Myotubular Myopathy Following AAV-Mediated Gene Replacement Molecular.

Volume 26, Issue 4, Pages (April 2018)

674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.

287. Improved Outcomes Following Drug-Resistant Immunotherapy in a Human Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme Harold T.

Molecular Therapy Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)

In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)

372. Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno- Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency Molecular.

521. AAV Immunotherapy Induces Functional Antigen Specific Regulatory T-Cells to a Neuroantigen: A Potential Treatment for MS Brad E. Hoffman Molecular.

483. In Vivo DMD Gene Editing in Muscles and Muscle Stem Cells of Dystrophic Mice Mohammadsharif Tabebordbar, Kexian Zhu, Jason Cheng, Jeffrey Widrick,

Rajendra N. Mitra, Min Zheng, Zongchao Han

773. Detection of RNA Interference (RNAi) Mediated mRNA Cleavage in Fresh Injected Tumor Tissue from Patients in a Phase I Trial of pbi-shRNA™ Lipoplex.

740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells Molecular Therapy Volume 20, Pages S285-S286.

Molecular Therapy Volume 21, Pages S247-S248 (May 2013)

Vanadium: A Panacea for Resistance to Oncolytic Immunotherapy?

Shigeki Yagyu, Malcolm K. Brenner

86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy Molecular Therapy Volume 20, Pages S35-S36.

297. Minimally Invasive Implantation of Autologous Chondrocytes Transduced with rAAV5-IGF-I Improves Longterm Cartilage Repair in Full-Thickness Chondral.

Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy by Olivier Humbert, Frieda Chan, Yogendra S. Rajawat,

Morton J Cowan, Hans-Peter Kiem Molecular Therapy

Jingxian Feng, Jiawen Wang, Junsheng Lin, Yong Diao

Shirley Wong, Roderick A. Slavcev

624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results Molecular.

Presentation transcript:

441. Direct Comparison of EF1α and PGK Promoters Reveals Superior Performance of the PGK Promoter for Expression of the Common Gamma Chain in a Canine Model of In Vivo Foamy Virus Gene Therapy for Severe Combined Immunodeficiency Christopher R. Burtner, Humbert Olivier, Patricia O'Donnell, Nicholas Hubbard, Daniel Humphrys, Jennifer E. Adair, Grant D. Trobridge, Troy R. Torgerson, Andrew M. Scharenberg, David J. Rawlings, Peter J. Felsburg, Hans-Peter Kiem Molecular Therapy Volume 23, Pages S174-S175 (May 2015) DOI: 10.1016/S1525-0016(16)34050-3 Copyright © 2015 The American Society of Gene & Cell Therapy Terms and Conditions

Molecular Therapy 2015 23, S174-S175DOI: (10 Molecular Therapy 2015 23, S174-S175DOI: (10.1016/S1525-0016(16)34050-3) Copyright © 2015 The American Society of Gene & Cell Therapy Terms and Conditions